Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation-Reference-Cited by-同舟云学术

Validation of single nucleotide polymorphisms in invasive aspergillosis following hematopoietic cell transplantation

Published:2017-05-11 Issue:19 Volume:129 Page:2693-2701
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Fisher Cynthia E.¹²,Hohl Tobias M.³,Fan Wenhong⁴,Storer Barry E.⁵,Levine David M.⁶,Zhao Lu Ping⁴,Martin Paul J.¹⁵,Warren Edus H.⁵,Boeckh Michael¹²,Hansen John A.¹⁵

Affiliation:

1. Department of Medicine, University of Washington, Seattle, WA;

2. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA;

3. Infectious Disease Service, Department of Medicine, and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, NY;

4. Division of Public Health Sciences, and

5. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA; and

6. Department of Biostatistics, University of Washington, Seattle, WA

Abstract

Key Points Two SNPs in PTX3 and CLEC7a previously associated with development of proven or probable invasive aspergillosis were validated. Thirteen SNPs in 9 genes were associated at P ≤ .05 with development of IA using a different genetic model than the original study.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/129/19/2693/1400129/blood743294.pdf

Reference37 articles.

1. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality;Upton;Clin Infect Dis,2007

2. Factors associated with mortality in transplant patients with invasive aspergillosis;Baddley;Clin Infect Dis,2010

3. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry;Steinbach;J Infect,2012

4. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial;Maertens;Lancet,2016

5. Combination antifungal therapy for invasive aspergillosis: a randomized trial;Marr;Ann Intern Med,2015

Cited by 82 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interplay between host humoral pattern recognition molecules controls undue immune responses against Aspergillus fumigatus;Nature Communications;2024-08-14

2. Validating genetic variants in innate immunity linked to infectious events in acute myeloid leukemia post-induction chemotherapy;Genes & Immunity;2024-07-09

3. An Update on Breakthrough Invasive Mold Infections;Mycopathologia;2024-06-13

4. Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis;mBio;2024-06-12

5. The epidemiology of invasive fungal infections in transplant recipients;Biomedical Journal;2024-06